Tumor-localization by adoptively transferred, interleukin-2-activated NK cells leads to destruction of well-established lung metastases

International Journal of Cancer

Volumn 105, Issue 4, 2003, Pages 512-519

  Yang, Qin ^a   Hokland, Marianne E ^b   Bryant, John L ^a   Zhang, Yuquing ^a   Nannmark, Ulf ^c   Watkins, Simon C ^a   Goldfarb, Ronald H ^d   Herberman, Ronald B ^a   Basse, Per H ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Immunotherapy; Interleukin 2; Lymphocyte traffic; Metastasis; Natural killer cells

Indexed keywords

MACROGOL; RECOMBINANT INTERLEUKIN 2;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL INFILTRATION; FEMALE; IMMUNOTHERAPY; LUNG METASTASIS; MORPHOLOGY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TUMOR LOCALIZATION; TUMOR VOLUME;

ADOPTIVE TRANSFER; ANIMALS; CARCINOMA, LEWIS LUNG; FEMALE; INJECTIONS, INTRAVENOUS; INTERLEUKIN-2; KILLER CELLS, NATURAL; LUNG NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; TUMOR CELLS, CULTURED;

EID: 0038274028     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11119     Document Type: Article

References (28)

1. Herberman RB, Holden HT. Natural cell-mediated immunity. Adv Cancer Res 1978;27:305-77.
2. Riccardi C, Puccetti P, Santoni A, Herberman RB. Rapid in vivo assay of mouse natural killer cell activity. J Natl Cancer Inst 1979;63:1041-5.
3. Gorelik E, Wiltrout RH, Okumura K, Habu S, Herberman RB. Role of NK cells in the control of metastatic spread and growth of tumor cells in mice. Int J Cancer 1982;30:107-12.
4. Wiltrout RH, Herberman RB, Zhang SR, Chirigos MA, Ortaldo JR, Green KM Jr, Talmadge JE. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J Immunol 1985;134:4267-75.
5. Coca S, Perez-Piqueras J, Martinez D, Colmenarejo A, Saez MA, Vallejo C, Martos JA, Moreno M. The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer 1997;79:2320-8.
6. Brunda MJ, Rosenbaum D, Stern L. Inhibition of experimentally-induced murine metastases by recombinant alpha interferon: correlation between the modulatory effect of interferon treatment on natural killer cell activity and inhibition of metastases. Int J Cancer 1984;34:421-6.
7. Whiteside TL, Herberman RB. The biology of human natural killer cells. Ann Ist Super Sanita 1990;26:335-48.
8. Sedlmayr P, Rabinowich H, Winkelstein A, Herberman RB, Whiteside TL. Generation of adherent lymphokine activated killer (A-LAK) cells from patients with acute myelogenous leukaemia. Br J Cancer 1992;65:222-8.
9. Gunji Y, Vujanovic NL, Hiserodt JC, Herberman RB, Gorelik E. Generation and characterization of purified adherent lymphokine-activated killer cells in mice. J Immunol 1989;142:1748-54.
10. Vujanovic NL, Herberman RB, Olszowy MW, Cramer DV, Salup RR, Reynolds CW, Hiserodt JC. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells. Cancer Res 1988;48:884-90.
11. Schwarz RE, Vujanovic NL, Hiserodt JC. Enhanced antimetastatic activity of lymphokine-activated killer cells purified and expanded by their adherence to plastic. Cancer Res 1989;49:1441-6.
12. Felgar RE, Hiserodt JC. In vivo migration and tissue localization of highly purified lymphokine-activated killer cells (A-LAK cells) in tumor-bearing rats. Cell Immunol 1990;129:288-98.
13. Nannmark U, Johansson BR, Bryant JL, Unger ML, Hokland ME, Goldfarb RH, Basse PH. Microvessel origin and distribution in pulmonary metastases of B16 melanoma: implication for adoptive immunotherapy. Cancer Res 1995;55:4627-32.
14. Jimenez M, Kameyama K, Maloy WL, Tomita Y, Hearing VJ. Mammalian tyrosinase: biosynthesis, processing, and modulation by melanocyte-stimulating hormone. Proc Natl Acad Sci USA 1988;85:3830-4.
15. Jimenez M, Maloy WL, Hearing VJ. Specific identification of an authentic clone for mammalian tyrosinase. J Biol Chem 1989;264:3397-403.
16. Samaraweera P, Donatien PD, Qazi S, Kobayashi T, Hearing VJ, Panthier JJ, Orlow SJ. Identification and characterization of a melanocyte-specific novel 65-kDa peripheral membrane protein. Eur J Biochem 1999;266:924-34.
17. Kobayashi T, Urabe K, Orlow SJ, Higashi K, Imokawa G, Kwon BS, Potterf B, Hearing VJ. The Pmel 17/silver locus protein. Characterization and investigation of its melanogenic function. J Biol Chem 1994;269:29198-205.
18. Basse PH, Whiteside TL, Herberman RB. Use of activated natural killer cells for tumor immunotherapy in mouse and human. Methods Mol Biol 2000;121:81-94.
19. Hagenaars M, Ensink NG, Koelemij R, Basse PH, Eggermont AM, van de Velde CJ, Fleuren GJ, Kuppen PJ. Regional administration of natural killer cells in a rat hepatic metastasis model results in better tumor infiltration and anti-tumor response than systemic administration. Int J Cancer 1998;75:233-8.
20. Hagenaars M, Zwaveling S, Kuppen PJ, Ensink NG, Eggermont AM, Hokland ME, Basse PH, van de Velde CJ, Fleuren GJ, Nannmark U. Characteristics of tumor infiltration by adoptively transferred and endogenous natural-killer cells in a syngeneic rat model: implications for the mechanism behind anti-tumor responses. Int J Cancer 1998; 78:783-9.
21. Kuppen PJ, Basse PH, Goldfarb RH, Van De Velde CJ, Fleuren GJ, Eggermont AM. The infiltration of experimentally induced lung metastases of colon carcinoma CC531 by adoptively transferred interleukin-2-activated natural killer cells in Wag rats. Int J Cancer 1994; 56:574-9.
22. Basse PH, Nannmark U, Johansson BR, Herberman RB, Goldfarb RH. Establishment of cell-to-cell contact by adoptively transferred adherent lymphokine-activated killer cells with metastatic murine melanoma cells. J Natl Cancer Inst 1991;83:944-50.
23. Basse PH, Goldfarb RH, Herberman RB, Hokland ME. Accumulation of adoptively transferred A-NK cells in murine metastases: kinetics and role of interleukin-2. In Vivo 1994;8:17-24.
24. Hokland M, Kjaergaard J, Kuppen PJ, Nannmark U, Agger R, Hokland P, Basse P. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 hr after inoculation. In Vivo 1999;13:199-204.
25. Basse P, Herberman RB, Nannmark U, Johansson BR, Hokland M, Wasserman K, Goldfarb RH. Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases. J Exp Med 1991;174:479-88.
26. Kjaergaard J, Hokland M, Nannmark U, Hokland P, Basse P. Infiltration patterns of short- and long-term cultured A-NK and T-LAK cells following adoptive immunotherapy. Scand J Immunol 1998;47:532-40.
27. Hagenaars M, Ensink NG, Basse PH, Hokland M, Nannmark U, Eggermont AM, van de Velde CJ, Fleuren GJ, Kuppen PJ. The microscopic anatomy of experimental rat CC531 colon tumour metastases: consequences for immunotherapy? Clin Exp Metastasis 2000;18:189-96.
28. Kuppen PJ, van der Eb MM, Jonges LE, Hagenaars M, Hokland ME, Nannmark U, Goldfarb RH, Basse PH, Fleuren GJ, Hoeben RC, van de Velde CJ. Tumor structure and extracellular matrix as a possible barrier for therapeutic approaches using immune cells or adenoviruses in colorectal cancer. Histochem Cell Biol 2001;115:67-72.